At Jubilant Biosys, Quality is a journey towards continual improvement. Every employee strives to provide High Quality of Innovation be it in products or services. Our ability to be the preferred collaborator in the Drug Discovery domain is sustained by our commitment to comply with and continually improve our Quality Systems and to provide:

• A highly secured data management and work environment

• A quality platform for collaboration

• Innovative and cost effective solutions

Jubilant Biosys is the first Drug Discovery Company, which has been certified ISO 27001:2005 Information Security Management System (ISMS) by BSI (British Standards Institution) Management Systems India Private Limited, accredited by The United Kingdom Accreditation Service (UKAS). The scope of the certificate is for: Informatics and Drug Discovery activities which include molecular modeling, medicinal chemistry, structural biology, invitro / invivo biology and pharmacokinetics, and information technology services to the global pharmaceutical industry including all support functions like human resource, administration, finance, quality, supply chain management, business development, intellectual property and legal functions.

People, process and technology are critical to our company for the conduct of our business. By establishing, documenting, implementing, monitoring, reviewing and maintaining an Information Security Management System (ISMS) based on the ISO 27001:2005 standard, we have greater confidence in our personnel and the information security framework, and offer better assurance to our business partners and customers. As a part of ISMS, we also address Business Continuity requirements in adverse conditions.

Jubilant Biosys ensures the management of customer's critical information based on key Principles - Confidentiality, Integrity and Availability, which constitute basic framework of ISO 27001:2005.

Jubilant Biosys is the first Indian drug discovery company that is implementing Lean Six Sigma Practices to enhance efficiencies, productivity and continuous improvements in its processes.

QUALITY ASSURANCE
As Jubilant Biosys is involved in basic drug discovery activities, we have a well experienced and independent Quality Assurance (QA) team to facilitate Good Research Practices in all the laboratories across Jubilant Biosys. By implementing GRP practices, we ensure the delivery of reliable results, which are relevant, traceable, reproducible and auditable. QA, in addition monitors the study related activities in DMPK laboratory. The QA group functions as per its own set of Standard Operating Procedures written based on the principles of GLP. The implementation and maintenance of SOP system is being managed effectively by the QA group. The QA reviews study plans, draft and final reports and inspects the critical phases of studies, facilities and routine processes in DMPK labs. In addition, QA is involved in validation of equipment, software etc. and maintain the relevant copies of the SOPs, study plans and master schedule.
	Back